ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,958 | -32.7% | 26,770 | -13.7% | 0.00% | – |
| Q2 2023 | $240,747 | +3912.4% | 31,024 | +2574.5% | 0.00% | – |
| Q1 2023 | $6,000 | +149900.0% | 1,160 | +52.6% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 760 | -94.5% | 0.00% | – |
| Q3 2022 | $44,000 | +63.0% | 13,744 | +132.1% | 0.00% | – |
| Q2 2022 | $27,000 | -74.3% | 5,922 | -69.9% | 0.00% | – |
| Q1 2022 | $105,000 | -54.9% | 19,654 | +23.9% | 0.00% | – |
| Q4 2021 | $233,000 | -49.2% | 15,860 | -27.7% | 0.00% | – |
| Q3 2021 | $459,000 | +57.7% | 21,940 | +33.5% | 0.00% | – |
| Q2 2021 | $291,000 | +1.7% | 16,435 | +40.8% | 0.00% | – |
| Q1 2021 | $286,000 | -15.1% | 11,674 | +17.3% | 0.00% | – |
| Q4 2020 | $337,000 | +349.3% | 9,951 | +206.6% | 0.00% | – |
| Q3 2020 | $75,000 | -64.3% | 3,246 | -47.8% | 0.00% | – |
| Q2 2020 | $210,000 | – | 6,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |